SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-064987
Filing Date
2024-03-11
Accepted
2024-03-11 17:28:33
Documents
9
Effectiveness Date
2024-03-11

Document Format Files

Seq Description Document Type Size
1 S-3ASR d787664ds3asr.htm S-3ASR 373967
2 EX-4.2 d787664dex42.htm EX-4.2 284612
3 EX-5.1 d787664dex51.htm EX-5.1 25694
4 EX-23.2 d787664dex232.htm EX-23.2 1301
5 EX-FILING FEES d787664dexfilingfees.htm EX-FILING FEES 60360
6 GRAPHIC g787664dsp56.jpg GRAPHIC 5167
7 GRAPHIC g787664dsp57.jpg GRAPHIC 2312
8 GRAPHIC g787664g29q80.jpg GRAPHIC 35708
9 GRAPHIC g787664g45y99.jpg GRAPHIC 44464
  Complete submission text file 0001193125-24-064987.txt   868351
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277829 | Film No.: 24739252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)